GlassScriptPhysician profile
Laura M Morgigno
NPI 1043658180
$1,194.54
in general payments reported to CMS, 2019-2025
21 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $86.36 · 2021: $49.90 · 2022: $151 · 2023: $247 · 2024: $132 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.41 | 2019-2024 | |
| Astellas Pharma US INC | $145.90 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $144.23 | 2019-2025 | |
| Optumhealth Care Solutions, LLC | $89.11 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Mayne Pharma Commercial LLC | $75.70 | 2022-2025 | |
| Hologic Sales and Service, LLC | $67.94 | 2022-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Organon LLC | $58.91 | 2022-2025 | Jada System |
| Coopersurgical, INC. | $53.19 | 2024 | Paragard T 380a |
| Exact Sciences Corporation | $44.86 | 2023-2024 | Cologuard Collection Kit |
| Ethicon US, LLC | $44.69 | 2019-2023 | Enseal |
| Pfizer INC. | $42.37 | 2025 | |
| Therapeuticsmd, INC. | $36.29 | 2022 | |
| Lupin INC. | $26.31 | 2019 | |
| Aspira Women'S Health INC | $23.66 | 2024 | Ova1 |
| Alydia Health | $18.12 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $17.24 | 2022 | |
| Baxter Healthcare | $15.56 | 2020 | |
| Avion Pharmaceuticals | $14.86 | 2019 | |
| Daiichi Sankyo INC. | $13.76 | 2020 | |
| Amgen INC. | $12.36 | 2019 | |
| Boston Scientific Corporation | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Morgigno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.